ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
119.804,10
-0,40%
S&P 500
5.925,88
0,75%
US Dollar vs BRL
6,2002
-1,61%
Bitcoin
97.059,29
2,83%
Brent Oil
76,155
3,11%
As Melhores Corretoras Online
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Acurx Pharmaceuticals Inc (ACXP)

  7. Acurx Pharmaceuticals Inc (ACXP) Notícias

ACXP

Acurx Pharmaceuticals (ACXP)

Acurx Pharmaceuticals Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ACXP
DataHoraFonteTítuloCódigoCompanhia
09/12/202410:00PR Newswire (US)Acurx Updates Phase 3 Readiness for Ibezapolstat in C. difficile Infection Based on Recent FDA and EMA CommunicationsNASDAQ:ACXPAcurx Pharmaceuticals Inc
20/11/202409:01PR Newswire (US)Acurx Board of Directors Approves Bitcoin as Treasury Reserve AssetNASDAQ:ACXPAcurx Pharmaceuticals Inc
13/11/202409:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACXPAcurx Pharmaceuticals Inc
13/11/202409:00PR Newswire (US)Acurx Pharmaceuticals, Inc. Reports Third Quarter 2024 Results and Provides Business UpdateNASDAQ:ACXPAcurx Pharmaceuticals Inc
21/10/202408:00PR Newswire (US)Acurx Announces New Bile Acid and Microbiome Analyses from Ph2b Trial of Ibezapolstat in CDI Patients Presented at IDWeek Scientific ConferenceNASDAQ:ACXPAcurx Pharmaceuticals Inc
17/10/202409:00PR Newswire (US)Acurx Pharmaceuticals Announces Participation at The Spartan Capital Investor Conference to Showcase Growth Companies and Foster High-Level Investor EngagementNASDAQ:ACXPAcurx Pharmaceuticals Inc
16/10/202409:00PR Newswire (US)Acurx Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 13, 2024NASDAQ:ACXPAcurx Pharmaceuticals Inc
26/09/202408:00PR Newswire (US)Acurx Announces Additional Ibezapolstat Ph2b Results in CDI as well as Anthrax (B. anthracis) Susceptibility to ACX-375 AnaloguesNASDAQ:ACXPAcurx Pharmaceuticals Inc
24/09/202408:00PR Newswire (US)Acurx Announces Results of Its Pioneering Research with Ibezapolstat in Collaboration with Leiden University Medical Center at the Premier International C. difficile SymposiumNASDAQ:ACXPAcurx Pharmaceuticals Inc
26/08/202410:15GlobeNewswire Inc.New to The Street Announces its Five Corporate Interviews, Airing Episode 591 on the Fox Business Network, Tonight Monday, August 26, 2024, at 10:30 PM PTNASDAQ:ACXPAcurx Pharmaceuticals Inc
26/08/202408:00PR Newswire (US)ACURX PHARMACEUTICALS ANNOUNCES PARTICIPATION AT THE H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:ACXPAcurx Pharmaceuticals Inc
19/08/202410:20GlobeNewswire Inc.New to The Street Announces Episode 590, Five Corporate Interviews, Airing on the Fox Business Network, Tonight Monday, August 19, 2024, at 10:30 PM PTNASDAQ:ACXPAcurx Pharmaceuticals Inc
09/08/202410:30GlobeNewswire Inc.New to The Street TV Announces Episode 583, Five Riveting Business Guest Interviews, Airs on Bloomberg TV as Sponsored Programming, Saturday, August 10, 2024, at 6:30 PM ETNASDAQ:ACXPAcurx Pharmaceuticals Inc
09/08/202408:01PR Newswire (US)Acurx Pharmaceuticals, Inc. Reports Second Quarter 2024 Results and Provides Business UpdateNASDAQ:ACXPAcurx Pharmaceuticals Inc
17/07/202408:00PR Newswire (US)USPTO Grants Acurx Pharmaceuticals New Patent for Ibezapolstat to Treat CDI While Reducing Recurrence of Infection and Improving Health of the Gut MicrobiomeNASDAQ:ACXPAcurx Pharmaceuticals Inc
16/07/202408:00PR Newswire (US)Acurx Pharmaceuticals, Inc. to Discuss Second Quarter 2024 Financial Results on August 9, 2024 Conference Call and Provide Business UpdateNASDAQ:ACXPAcurx Pharmaceuticals Inc
15/07/202408:00PR Newswire (US)Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results for CDI at Scientific ConferenceNASDAQ:ACXPAcurx Pharmaceuticals Inc
18/06/202417:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACXPAcurx Pharmaceuticals Inc
06/06/202410:30GlobeNewswire Inc.New to The Street Announces Episode 576, Four Business Guest Interviews, Airs on Bloomberg TV as Sponsored Programming, Tonight, Thursday, June 6, 2024, at 9:30 PM PTNASDAQ:ACXPAcurx Pharmaceuticals Inc
15/05/202410:00PR Newswire (US)Acurx Announces Successful FDA End-of-Phase 2 Meeting and Phase 3 Readiness for Ibezapolstat in the Treatment of C. difficile InfectionNASDAQ:ACXPAcurx Pharmaceuticals Inc
15/05/202408:50IH Market NewsU.S. Index Futures Flat Ahead of April CPI Data Release, Oil Prices DropNASDAQ:ACXPAcurx Pharmaceuticals Inc
15/05/202408:00PR Newswire (US)Acurx Pharmaceuticals, Inc. Reports First Quarter 2024 Results and Provides Business UpdateNASDAQ:ACXPAcurx Pharmaceuticals Inc
14/05/202417:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ACXPAcurx Pharmaceuticals Inc
02/05/202408:00PR Newswire (US)Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results at ESCMID Global 2024 Scientific ConferenceNASDAQ:ACXPAcurx Pharmaceuticals Inc
25/04/202411:12PR Newswire (US)Acurx Pharmaceuticals Announces Presentation of Ibezapolostat Phase 2 Clinical Trial Results at upcoming ESCMID 2024 Scientific ConferenceNASDAQ:ACXPAcurx Pharmaceuticals Inc
23/04/202411:57PR Newswire (US)Acurx Pharmaceuticals, Inc. to Discuss First Quarter 2024 Financial Results on May 15, 2024 Conference Call and Provide Business UpdateNASDAQ:ACXPAcurx Pharmaceuticals Inc
19/03/202408:33IH Market NewsUnilever Initiates Ice Cream Division Spin-Off and Announces Job Cuts; Berkshire Ramps Up Share Buyback Efforts, and MoreNASDAQ:ACXPAcurx Pharmaceuticals Inc
18/03/202408:12IH Market NewsAnticipation Builds on Wall Street for Federal Reserve’s Upcoming Policy Moves; WTI and Brent See UpticksNASDAQ:ACXPAcurx Pharmaceuticals Inc
18/03/202408:01PR Newswire (US)Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2023 Results and Provides Business UpdateNASDAQ:ACXPAcurx Pharmaceuticals Inc
04/03/202409:01PR Newswire (US)Acurx Pharmaceuticals, Inc. to Discuss Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024 Conference Call and Provide Business UpdateNASDAQ:ACXPAcurx Pharmaceuticals Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:ACXP

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
AZEV4
AZEVEDO PN
BOV
IDIV
Dividend
BOV
PRIO3
PETRORIO ON
BOV
AMER3
Americanas ON
BOV
RCSL4
RECRUSUL PN
BOV
FICT3
Fictor Alimentos ON
BOV
EZTC3
EZTEC ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
RAIZ4
Raizen S.A PN
BOV
AZEV3
AZEVEDO ON
BOV
AMOB3
Automob Participacoes ON
BOV
WEST3
Westwing Comercio Vareji... ON
BOV
HOOT4
HOTEIS OTHON PN
BOV
GFSA3
GAFISA ON
BOV
BRAV3
Brava Energia ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados